Japanese pharmaceutical companies showed double-digit growth in revenue and operating profit

According to the audit report of seven Japanese pharmaceutical companies who have assets of more than 10 billion won and receive external audits (two companies settle accounts in end of December, 5 companies settle accounts in end of March) in 2013, they showed double-digit growth in revenue and operating profit.

Last year, a total of seven companies achieved sales of 7,190 billion in Korea ma...